查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1922905

床边尿袋市场按产品类型、材质类型、最终用户和分销管道划分－2026-2032年全球预测

Bedside Urine Bag Market by Product Type, Material Type, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，床边尿袋市场价值将达到 20.1 亿美元，到 2026 年将成长至 21.4 亿美元，到 2032 年将达到 35.6 亿美元，复合年增长率为 8.52%。

关键市场统计数据
基准年 2025 20.1亿美元
预计年份：2026年 21.4亿美元
预测年份 2032 35.6亿美元
复合年增长率 (%) 8.52%

这是一份简洁的策略性介绍，阐述了临床需求、材料选择和不断发展的护理模式如何重新定义床边尿袋采购者的优先事项。

床边尿袋是患者照护和居家照护中普遍存在却又常常被忽视的要素，在病患监测、感染预防和工作流程效率方面发挥着至关重要的作用。临床医生依赖设备的可靠性和明确的测量功能来指导液体管理决策。同时，采购团队在製定合约时需要权衡成本、供应连续性和法规遵循。近年来，随着医疗服务模式的转变以及技术的进步，人们开始重新评估产品规格、材料选择和分销模式。出于对病人安全的考虑，例如减少导尿管相关尿道感染和改善人体工学，人们更加重视产品设计和临床医生培训。同时，居家医疗和远端监测的兴起也改变了人们对便携性、一次性使用性和连接性的要求。了解临床需求、材料科学、法规要求和通路之间的相互作用，是製定可行策略的基础。本文提供了一个分析框架，将床旁尿袋置于临床效用、供应链韧性和产品创新三者的交汇点上进行探讨。这为评估产品系列、伙伴关係和投资重点的相关人员设定了预期。

数位连结、永续材料趋势和分销创新如何融合，从根本上重塑产品设计和筹资策略

床边尿袋市场格局正经历变革，其驱动力包括医疗数位化、永续性以及不断演变的供应链。在某些医疗环境中，医疗设备互联已不再是新鲜事物，而是营运的必要条件。物联网尿液计量器可远端监测，将数据整合到电子健康记录中，从而能够及早识别患者病情恶化。与技术进步同步，日益严格的监管审查和采购政策的转变，促使人们关注非聚氯乙烯（PVC）材料，例如生物基聚合物和热可塑性橡胶，这些材料可减少长期环境影响，并支持医院的永续性目标。随着电子商务和直接面向製造商通路的扩张，分销模式也在重组，实现了快速补货和多样化的定价结构，这对传统的全国性和区域分销商模式提出了新的挑战。居家医疗的成长和远端监测服务的扩展，进一步推动了产品在非急性环境下的便携性、易用性和经临床医生检验的准确性方面的重新设计。因此，策略重点正从单纯的单位成本优化转向「总医疗成本」概念，涵盖设备生命週期、感染控制性能和数据驱动的临床价值。这些复杂的变化要求製造商和供应商合作伙伴协调产品创新、法规遵循和分销策略，以保持竞争力并满足临床需求。

评估2025年关税对医院尿袋相关人员供应链、采购和采购策略的系统性影响

计划于2025年实施的进口医疗设备组件和聚合物新关税，正促使各机构重新评估筹资策略和供应链结构。关税导致投入成本增加，促使企业更加重视供应商多元化、关键组件的近岸生产以及重新谈判长期合同，以保障利润率并确保业务连续性。为此，一些製造商正在寻找替代材料，并在法规和性能允许的情况下加快采用生物基聚合物和热可塑性橡胶。医院和集团采购组织正在将物流成本、海关延误和库存持有成本纳入采购决策，并更严格地审查总到岸成本。关税也促使国内製造地加大对流程优化和自动化方面的投资，以在保持具有竞争力的前置作业时间的同时缓解成本压力。通路也受到影响，区域分销商和全国供应链正在重新评估定价结构，并利用电子商务和直接面向製造商的模式来绕过部分中间商利润。临床医生和采购团队需要在熟悉现有产品和快速更换供应商带来的营运风险之间权衡取舍。最终，关税的累积影响已将供应链风险管理、材料多功能性和合约柔软性提升为製造商、供应链合作伙伴和医疗系统采购领导者必须关注的策略问题。

深入的细分市场分析揭示了终端用户环境、产品创新、通路和材料选择如何驱动差异化产品和市场推广策略的发展。

细分市场趋势揭示了不同的需求驱动因素和设计重点，产业相关人员应将这些因素纳入其产品蓝图和市场推广计画。按最终用户划分，门诊手术中心和诊所优先考虑紧凑、易于储存的解决方案，以满足周转率和感染控制要求。医院则寻求可扩展的库存管理和高吞吐量的符合人体工学的设计，用于集中监测。随着远端监测服务的扩展，居家医疗越来越需要便携性和简化的使用者介面。依产品类型划分，防回流尿袋强调安全性和阀门可靠性，以保障弱势患者族群的需求。标准尿袋有双隔间和单隔间两种配置，兼顾成本和性能，以满足不同的尿量测量需求。尿量计分为适用于既定临床工作流程的传统类型和支援物联网的尿量计，后者增加了连接性和分析功能，可用于更进阶的监测。按分销管道划分，医院药房在大量采购中仍发挥核心作用。同时，医疗设备批发商在国家和地区层面运营，提供丰富的选择和本地化的物流支援。包括电商平台和厂商直销在内的线上销售管道正在重塑补货週期和价格透明度。零售药局也积极拓展门诊和居家医疗等细分市场。就材料类型而言，聚氯乙烯（PVC）因其成本效益和成熟的加工过程而仍被广泛使用。同时，生物基聚合物和热可塑性橡胶等非PVC替代品因其更优异的环境性能和合规性而备受关注。总而言之，这些细分观点指南研发、临床检验和商业投资的重点，以满足特定临床环境和产品偏好的需求。

区域趋势和监管差异（美洲、欧洲、中东和非洲、亚太地区）需要量身定制的商业性、监管和生产应对措施。

区域趋势导致监管、采购和实施模式存在显着差异，要求製造商和经销商采取量身定制的策略。在美洲，医疗系统优先考虑规模、与整合电子健康记录的兼容性以及评估供应商可靠性和临床证据的采购协议。无论是私人还是公共支付方，都越来越关注基于价值的结果，鼓励采用能够减少併发症和提高工作流程效率的解决方案。在欧洲、中东和非洲，复杂的法规环境和多样化的采购模式尤其重视本地监管专业知识、灵活的分销网络以及对区域环境指令的严格遵守。该地区小规模的市场可以率先在私人医疗机构中采用永续材料和物联网测量技术。在亚太地区，医院容量的快速扩张、对居家医疗需求的增长以及对数位医疗基础设施的投资，为扩充性的解决方案创造了机会，包括低成本、坚固耐用的解决方案以及高所得都市区更先进的物联网解决方案。无论在哪个地区，关税政策、物流复杂性和本地製造能力都会影响近岸外包、经销商合作关係和服务模式的决策。针对这些区域差异调整产品特性、监管文件和商业性策略，对于持续推广和提高营运效率至关重要。

关键的竞争与伙伴关係洞察，揭示了产品差异化、供应链韧性和分销策略如何决定供应商的吸引力和成长潜力。

床边尿袋市场的竞争格局由成熟製造商、创新医疗技术公司和专业本地供应商组成。领先企业透过持续投资临床检验、产品人体工学和供应链韧性来脱颖而出，而新参与企业则寻求透过整合互联功能、永续材料或精益分销模式来加快产品交付速度。医疗设备製造商和医院技术团队之间正在建立策略联盟，以试点支援物联网的尿液计量器和远端监测工作流程，这些联盟通常辅以针对性的临床医生培训和数据整合工作。拥有多元化全球製造地和冗余供应商网路的製造商展现出应对关税和物流中断的韧性，而依赖单一来源聚合物的公司则面临更大的风险。分销策略正在多元化发展，一些公司加强了传统的全国性和区域分销商网络以维持服务覆盖范围，而另一些公司则拓展了製造商直销渠道和电子商务，以提高利润率和应对力。併购和联盟的重点在于扩展产品组合，以满足不同的终端用户需求，例如增加回流防止设计、双腔解决方案和数位化测量功能。监管合规记录、品质系统成熟度和透明的供应连续性计画正成为买家和合作伙伴评估潜在供应商的关键选择标准。

产业领导者现在必须采取切实可行的策略步骤，以加强价值链、加速高价值创新并重塑分销和临床合作模式。

产业领导者可以即时采取切实可行的措施来保护利润率，加速推广高价值产品，并增强应对监管和贸易逆风的能力。优先考虑关键聚合物原料的供应商多元化和近岸外包方案，同时投资于生物基聚合物和热可塑性橡胶等替代材料，以降低关税带来的成本压力。加速物联网尿流率计的开发和临床检验，在远端监测和数据整合能够带来可衡量的工作流程改善和临床效益的环境中创造价值。透过试点厂商直销和选择性电子商务项目来重组分销策略，以提高补货速度和价格透明度，并与国家和地区分销商协商灵活的合同，使奖励与服务水平达成协议保持一致。积极与医疗系统采购和临床团队合作，将产品规格与总医疗成本结果挂钩，尤其要利用能够减少併发症和护理时间的针对性试点研究。最后，将情境规划融入商业策略，为因应未来的政策变化做好准备。这包括对物流计划进行压力测试，并为高利用率设施维持缓衝库存。这些措施结合起来，可以增强您的竞争优势，并使您的组织能够抓住新的需求领域。

我们采用透明的检验调查方法，结合关键相关人员访谈、监管和文件分析、供应链映射以及专家同行评审，以得出可靠的结论。

本分析整合了透过结构化且透明的调查方法收集的定性和定量证据，该方法优先考虑可靠性和三角验证。主要研究包括对医院、门诊诊所和居家医疗机构的临床医生、采购经理、分销公司高管和医疗设备工程师进行结构化访谈，以了解实际环境中的设备性能标准、采购决策驱动因素和物流限制。次要研究包括分析监管文件、导管相关感染预防的临床指南、聚合物和生物基替代品的材料科学文献，以及与製造地和产能相关的公开文件。供应链图谱确定了聚合物原料、组装製程和分销点的关键节点，专利格局分析和产品规格审查则描述了创新轨迹。数据整合应用了交叉检验技术来协调不同相关人员的观点，并对分析中引用的所有文件进行了专家同行评审和资讯来源检验，作为品质保证流程。考虑到由于供应商专有协议和快速变化的关税政策而导致的完全透明性方面的局限性，我们进行了敏感性分析，以评估我们在多种营运情境下策略结论的稳健性。

本文概述了在日益增长的临床期望和政策压力下，整合产品、供应链和商业策略将如何决定主导地位。

床边尿袋产业正处于转折点，临床需求、永续性目标和贸易政策在此交汇，既带来风险也带来机会。技术应用，特别是物联网赋能的监测，正在为急诊和居家照护开闢新的临床价值途径，而材料创新则为应对环境和监管压力提供了有希望的方案。关税趋势凸显了供应商多元化、生产弹性和合约柔软性的重要性，而那些积极整合销售管道和数位补货的商业模式的经销商和製造商将获得竞争优势。此外，按最终用户、产品类型、分销管道和材料进行细分意味着「一刀切」的方法越来越难以奏效；相反，有针对性的产品差异化和地理市场策略至关重要。积极投资于临床检验、供应链韧性和与医疗保健系统建立合作伙伴关係的相关人员将最有能力将这些趋势转化为永续成长。简而言之，将循证产品开发与适应性供应和商业策略相结合，将决定哪些公司能够在床边尿袋发展的下一阶段蓬勃发展。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 床边尿袋市场依产品类型划分

  • 防逆流尿袋
  • 标准尿袋
    • 双腔型
    • 单室
  • 尿量计
    • 传统尿量计
    • 相容物联网的尿量计

9. 依材质类型分類的床边尿袋市场

  • 非氯乙烯
    • 生物基聚合物
    • 热可塑性橡胶
  • 聚氯乙烯

第十章 床边尿袋市场（依最终用户划分）

  • 门诊手术中心
  • 诊所
  • 居家医疗
  • 医院

第十一章 依分销管道分類的床边尿袋市场

  • 医院药房
  • 医疗批发商
    • 全国批发商
    • 区域批发商
  • 线上销售
    • 电子商务平台
    • 直接从製造商购买
  • 零售药房

第十二章 各地区床边尿袋市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 床边尿袋市场（依族群划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国床边尿袋市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国床边尿袋市场

第十六章 中国床边尿袋市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3M Company
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • Coloplast A/S
  • ConvaTec Group PLC
  • Crucial Medical Supply
  • Fresenius Kabi AG
  • Halyard Health
  • Hollister Incorporated
  • Lohmann & Rauscher International GmbH & Co. KG
  • Medline Industries, LP
  • Molnlycke Health Care AB
  • Nipro Corporation
  • Pelican Healthcare Ltd.
  • Smiths Group plc
  • Teleflex Incorporated
  • UXL Medical Limited
Product Code: MRR-867BED9A9E47

The Bedside Urine Bag Market was valued at USD 2.01 billion in 2025 and is projected to grow to USD 2.14 billion in 2026, with a CAGR of 8.52%, reaching USD 3.56 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.01 billion
Estimated Year [2026] USD 2.14 billion
Forecast Year [2032] USD 3.56 billion
CAGR (%) 8.52%

A concise strategic introduction explaining how clinical needs, material choices, and evolving care models are redefining bedside urine bag priorities for purchasers

The bedside urine bag remains a ubiquitous but often underexamined component of inpatient and home-based care delivery, serving a critical role in patient monitoring, infection prevention, and workflow efficiency. Clinicians rely on device reliability and clear measurement capability to inform fluid management decisions, while procurement teams balance cost, supply continuity, and regulatory compliance when defining contracts. Recent years have seen incremental technological advancements alongside changing care delivery patterns, prompting a reassessment of product specifications, material selection, and distribution models. Patient safety concerns, including catheter-associated urinary tract infection reduction and improved handling ergonomics, have placed greater emphasis on product design and clinician training. At the same time, the rise of home healthcare and remote monitoring is altering specifications for portability, disposability, and connectivity. Understanding these intersecting forces-clinical requirements, materials science, regulatory imperatives, and distribution pathways-creates the foundation for actionable strategy. This introduction frames the remainder of the analysis by situating bedside urine bags at the nexus of clinical utility, supply chain resilience, and product innovation, and sets expectations for stakeholders evaluating product portfolios, partnerships, and investment priorities.

How digital connectivity, sustainable material trends, and distribution innovations are converging to fundamentally reshape product design and procurement strategies

The landscape for bedside urine bags is undergoing transformative shifts driven by digitization of care, sustainability imperatives, and evolving channels of delivery. Device connectivity has moved beyond novelty to operational necessity in some care settings, with IoT-enabled urimeters enabling remote monitoring, data integration into electronic health records, and early recognition of patient deterioration. Parallel to technological advances, regulatory scrutiny and procurement preferences are accelerating interest in non-PVC materials, including bio-based polymers and thermoplastic elastomers, which reduce long-term environmental liabilities and support hospital sustainability goals. Distribution is also being reshaped as e-commerce and manufacturer-direct channels expand, offering faster replenishment and alternative pricing structures that challenge traditional national and regional distributor models. Home healthcare growth and the expansion of remote monitoring services are further prompting product redesign for portability, simplified use, and clinician-validated accuracy outside acute settings. Consequently, strategic priorities are shifting from pure unit-cost optimization to total-cost-of-care thinking that incorporates device lifecycle, infection control performance, and data-enabled clinical value. These combined shifts require manufacturers and supply partners to coordinate product innovation, regulatory engagement, and distribution strategies to remain competitive and clinically relevant.

Assessing the systemic implications of 2025 tariff measures on supply chains, material sourcing, and procurement strategy for bedside urine bag stakeholders

The introduction of new tariffs in 2025 affecting medical device components and polymer imports has prompted organizations to reassess sourcing strategies and supply chain architectures for bedside urine bags. Tariff-driven input cost inflation has placed renewed emphasis on supplier diversification, nearshoring of key components, and renegotiation of long-term agreements to protect margins and ensure continuity. In response, some manufacturers have shifted procurement toward alternative feedstocks, accelerating adoption of bio-based polymers and thermoplastic elastomers where regulatory and performance profiles allow. Hospitals and group purchasing organizations have increased scrutiny of total landed costs, factoring logistics, customs clearance delays, and inventory carrying costs into procurement decisions. Tariffs have also spurred investment in process optimization and automation in domestic manufacturing footprints to absorb cost pressure while maintaining competitive lead times. Distribution channels have been affected as well; regional distributors and national supply chains have had to revise pricing frameworks, while e-commerce and manufacturer-direct sales models have been leveraged to bypass some intermediary markups. Clinicians and procurement teams face the trade-off between established product familiarity and the operational risk associated with rapid supplier changes. Ultimately, the cumulative impact of tariffs has elevated supply chain risk management, material versatility, and contractual flexibility as strategic imperatives for manufacturers, supply chain partners, and health system procurement leaders alike.

In-depth segmentation analysis revealing how end-user settings, product innovations, distribution pathways, and material choices determine differentiated product and go-to-market priorities

Segment-specific dynamics reveal differentiated demand drivers and design priorities that industry players must integrate into product roadmaps and go-to-market plans. Based on end user, ambulatory surgical centers and clinics prioritize compact, easy-to-store solutions that support turnover and infection control requirements, hospitals demand scalable inventory and high-throughput ergonomics for intensive monitoring, and home healthcare increasingly requires portability and simplified user interfaces, particularly as remote monitoring services expand. Based on product type, anti-reflux urine bags emphasize patient safety and valve reliability for vulnerable populations, standard urine bags balance cost and performance across dual chamber and single chamber configurations to suit varying drainage and measurement needs, and urimeters split into conventional units favored for established clinical workflows and IoT-enabled urimeters that add connectivity and analytics for higher-acuity surveillance. Based on distribution channel, hospital pharmacies remain central to bundled procurement, while medical distributors operate at national and regional levels to provide breadth and localized logistics support; online sales channels including e-commerce platforms and manufacturer direct sales are reshaping replenishment cadence and price transparency, and retail pharmacies serve niche ambulatory and home settings. Based on material type, polyvinyl chloride continues to be widely used for its cost-effectiveness and established processing pathways even as non-polyvinyl chloride alternatives such as bio-based polymers and thermoplastic elastomers attract attention for improved environmental profiles and regulatory alignment. These segmentation lenses collectively guide where to focus R&D, clinical validation, and commercial investment to capture demand across care settings and product preferences.

Regional dynamics and regulatory distinctions across the Americas, Europe Middle East & Africa, and Asia-Pacific that require tailored commercial, regulatory, and manufacturing approaches

Regional dynamics create distinct regulatory, procurement, and adoption patterns that manufacturers and distributors must navigate with tailored strategies. In the Americas, health systems emphasize scale, integrated electronic health record compatibility, and purchasing contracts that reward supplier reliability and clinical evidence; private and public payers alike are increasingly focused on value-based outcomes, encouraging solutions that demonstrate reduced complications and improved workflow efficiency. In Europe, Middle East & Africa, the regulatory mosaic and diverse procurement models place a premium on local regulatory expertise, flexible distribution networks, and material compliance with regional environmental directives; smaller market pockets within the region can act as early adopters for sustainable materials or IoT-enabled measurement in private care facilities. In Asia-Pacific, rapid expansion of hospital capacity, strong home healthcare demand, and investments in digital health infrastructure create opportunities for scalable solutions, particularly for low-cost, robust designs alongside more advanced IoT offerings in higher-income urban centers. Across regions, tariff policies, logistics complexity, and local manufacturing capacity shape decisions about nearshoring, distributor partnerships, and service models. Tailoring product features, regulatory submissions, and commercial approaches to these regional nuances is essential for sustained uptake and operational efficiency.

Key competitive and partnership insights that reveal how product differentiation, supply chain resilience, and distribution strategies determine supplier attractiveness and growth potential

Competitive dynamics in the bedside urine bag space are being shaped by a mix of incumbent manufacturers, innovative medtech firms, and specialized local suppliers. Leading players differentiate through sustained investment in clinical validation, product ergonomics, and supply chain resilience, while challengers seek advantage by integrating connectivity, sustainable materials, or lean distribution models that reduce time-to-consumer. Strategic partnerships between device manufacturers and health system technology teams have emerged to pilot IoT-enabled urimeters and remote monitoring workflows, often supported by targeted clinician training and data integration efforts. Manufacturers with diversified global manufacturing footprints and redundant supplier networks have exhibited greater resilience to tariff and logistics shocks, whereas companies reliant on single-source polymer supplies face elevated risk. Distribution strategies vary: some firms double down on traditional national and regional distributor networks to maintain service coverage, while others scale manufacturer-direct channels and e-commerce to improve margins and responsiveness. Mergers and alliances have centered on broadening portfolios-adding anti-reflux designs, dual-chamber solutions, or digital measurement capabilities-to meet differentiated end-user requirements. For purchasers and partners assessing potential suppliers, evidence of regulatory compliance, quality systems maturity, and transparent supply continuity planning are becoming primary selection criteria.

Actionable strategic steps industry leaders should implement now to shore up supply chains, accelerate high-value innovations, and realign distribution and clinical engagement models

Industry leaders can take immediate, actionable steps to protect margins, accelerate adoption of higher-value products, and strengthen resilience in the face of regulatory and trade headwinds. Prioritize supplier diversification and nearshoring options for critical polymer inputs while simultaneously investing in material substitution pathways such as bio-based polymers and thermoplastic elastomers to reduce exposure to tariff-induced cost pressure. Accelerate development and clinical validation of IoT-enabled urimeters to capture value in settings where remote monitoring and data integration deliver measurable workflow or clinical benefits. Reconfigure distribution strategies by piloting manufacturer-direct replenishment or selective e-commerce programs to improve replenishment speed and pricing transparency, and negotiate flexible contracts with national and regional distributors that align incentives for service-level performance. Engage proactively with health system procurement and clinical teams to link product specifications to total cost of care outcomes, using targeted pilot studies to demonstrate reductions in complications or nursing time. Finally, integrate scenario-based planning into commercial strategy to prepare for further policy shifts, including stress-testing logistics plans and maintaining buffer inventories for high-use facilities. These measures can collectively enhance competitiveness and position organizations to capitalize on emerging demand segments.

A transparent, triangulated research methodology combining primary stakeholder interviews, regulatory and materials analysis, supply chain mapping, and expert peer review to ensure robust conclusions

This analysis synthesizes qualitative and quantitative evidence gathered through a structured and transparent research methodology that prioritizes reliability and triangulation. Primary research included structured interviews with clinicians across hospital, ambulatory, and home healthcare settings, procurement managers, distributor executives, and device engineers to capture real-world device performance criteria, purchasing triggers, and logistical constraints. Secondary research comprised regulatory documentation, clinical guidelines related to catheter-associated infection prevention, materials science literature on polymers and bio-based alternatives, and public filings pertinent to manufacturing footprints and capacity. Supply chain mapping identified key nodes for polymer feedstocks, assembly operations, and distribution hubs, while patent landscaping and product specification reviews were used to characterize innovation trajectories. Data synthesis applied cross-validation techniques to reconcile differing stakeholder perspectives, and quality assurance steps included expert peer review and source verification for all material cited in the analysis. Limitations are acknowledged where proprietary supplier agreements or rapidly evolving tariff policies restrict full transparency, and sensitivity checks were used to evaluate the robustness of strategic conclusions under multiple operational scenarios.

Concluding synthesis on how integrated product, supply chain, and commercial strategies will determine leading positions as clinical expectations and policy pressures intensify

The bedside urine bag sector stands at an inflection point where clinical expectations, sustainability goals, and trade policy converge to create both risk and opportunity. Technological adoption, particularly IoT-enabled monitoring, is unlocking new pathways to clinical value in acute and home care, while material innovation offers a credible response to environmental and regulatory pressures. Tariff dynamics have highlighted the importance of supplier diversification, manufacturing agility, and contracting flexibility, and distributors and manufacturers that adapt their commercial models to embrace direct channels and digital replenishment will gain competitive advantage. Moreover, segmentation across end users, product types, distribution channels, and materials underscores that one-size-fits-all approaches are increasingly untenable; instead, targeted product differentiation and regional market strategies are essential. Stakeholders who proactively invest in clinical validation, supply chain resilience, and collaborative partnerships with health systems will be best positioned to convert these trends into sustainable growth. In short, integrating evidence-based product development with adaptive supply and commercial strategies will determine who thrives in the next phase of bedside urine bag evolution.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bedside Urine Bag Market, by Product Type

  • 8.1. Anti-Reflux Urine Bag
  • 8.2. Standard Urine Bag
    • 8.2.1. Dual Chamber
    • 8.2.2. Single Chamber
  • 8.3. Urimeter
    • 8.3.1. Conventional Urimeter
    • 8.3.2. Iot-Enabled Urimeter

9. Bedside Urine Bag Market, by Material Type

  • 9.1. Non-Polyvinyl Chloride
    • 9.1.1. Bio-Based Polymers
    • 9.1.2. Thermoplastic Elastomer
  • 9.2. Polyvinyl Chloride

10. Bedside Urine Bag Market, by End User

  • 10.1. Ambulatory Surgical Center
  • 10.2. Clinics
  • 10.3. Home Healthcare
  • 10.4. Hospitals

11. Bedside Urine Bag Market, by Distribution Channel

  • 11.1. Hospital Pharmacy
  • 11.2. Medical Distributors
    • 11.2.1. National Distributors
    • 11.2.2. Regional Distributors
  • 11.3. Online Sales
    • 11.3.1. E-Commerce Platforms
    • 11.3.2. Manufacturer Direct Sales
  • 11.4. Retail Pharmacy

12. Bedside Urine Bag Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Bedside Urine Bag Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Bedside Urine Bag Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Bedside Urine Bag Market

16. China Bedside Urine Bag Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. 3M Company
  • 17.6. B. Braun Melsungen AG
  • 17.7. Baxter International Inc.
  • 17.8. Becton, Dickinson and Company
  • 17.9. Cardinal Health, Inc.
  • 17.10. Coloplast A/S
  • 17.11. ConvaTec Group PLC
  • 17.12. Crucial Medical Supply
  • 17.13. Fresenius Kabi AG
  • 17.14. Halyard Health
  • 17.15. Hollister Incorporated
  • 17.16. Lohmann & Rauscher International GmbH & Co. KG
  • 17.17. Medline Industries, LP
  • 17.18. Molnlycke Health Care AB
  • 17.19. Nipro Corporation
  • 17.20. Pelican Healthcare Ltd.
  • 17.21. Smiths Group plc
  • 17.22. Teleflex Incorporated
  • 17.23. UXL Medical Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL BEDSIDE URINE BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BEDSIDE URINE BAG MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BEDSIDE URINE BAG MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES BEDSIDE URINE BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA BEDSIDE URINE BAG MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BEDSIDE URINE BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY ANTI-REFLUX URINE BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY ANTI-REFLUX URINE BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY ANTI-REFLUX URINE BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY DUAL CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY DUAL CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY DUAL CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY SINGLE CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY SINGLE CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY SINGLE CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY CONVENTIONAL URIMETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY CONVENTIONAL URIMETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY CONVENTIONAL URIMETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY IOT-ENABLED URIMETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY IOT-ENABLED URIMETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY IOT-ENABLED URIMETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY BIO-BASED POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY BIO-BASED POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY BIO-BASED POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY THERMOPLASTIC ELASTOMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY THERMOPLASTIC ELASTOMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY THERMOPLASTIC ELASTOMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY POLYVINYL CHLORIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY POLYVINYL CHLORIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY POLYVINYL CHLORIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY MANUFACTURER DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY MANUFACTURER DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY MANUFACTURER DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS BEDSIDE URINE BAG MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA BEDSIDE URINE BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA BEDSIDE URINE BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA BEDSIDE URINE BAG MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE BEDSIDE URINE BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST BEDSIDE URINE BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA BEDSIDE URINE BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC BEDSIDE URINE BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN BEDSIDE URINE BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 172. GCC BEDSIDE URINE BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GCC BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. GCC BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 175. GCC BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 176. GCC BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. GCC BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 178. GCC BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. GCC BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. GCC BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 181. GCC BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION BEDSIDE URINE BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS BEDSIDE URINE BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 202. G7 BEDSIDE URINE BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. G7 BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. G7 BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 205. G7 BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 206. G7 BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. G7 BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 208. G7 BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. G7 BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. G7 BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 211. G7 BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 212. NATO BEDSIDE URINE BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. NATO BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. NATO BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 215. NATO BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 216. NATO BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. NATO BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 218. NATO BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. NATO BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. NATO BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 221. NATO BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES BEDSIDE URINE BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA BEDSIDE URINE BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)